Tender Details
Ref No 24653764
Document

Tender Notice

Bidding

National Competitive Bidding

Short Description

Register (V2),Register (V2),Plain Copier Paper (V3) Isi Marked To Is 14490,Packing List Envelope (V
Deadline *
Date 13 Feb 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location India
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 5306291
  • Location: Germany

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

  • Deadline: 05 Apr 2026
  • Ref No: 5304038
  • Location: Germany

Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Pemetrexed Atc L01Ba04

  • Deadline: 16 Apr 2026
  • Ref No: 5310172
  • Location: Germany

Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Bortezomib Atc L01Xg01

  • Deadline: 16 Apr 2026
  • Ref No: 5975023
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Mode

  • Deadline: 31 Jul 2026
  • Ref No: 5975224
  • Location: Germany

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred

  • Deadline: 30 Apr 2026
  • Ref No: 5975947
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Mode

  • Deadline: 31 Jul 2026
  • Ref No: 5226698
  • Location: Germany

Medicines With The Active Ingredient Combination Formoterol Glycopyrronium Bromide And Beclometasone Atc R03Al09

  • Deadline: 31 Mar 2026
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
  • Ref No: 8314020
  • Location: Germany

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred

  • Deadline: 31 Oct 2026
  • Ref No: 5718312
  • Location: Germany

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Bu

  • Deadline: 30 Apr 2026
  • Ref No: 3364386
  • Location: Lithunia

Crepe Paper For Steam Sterilization

  • Deadline: 18 Mar 2034
  • Ref No: 5977462
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form

  • Deadline: 10 May 2026
  • Ref No: 5977915
  • Location: Germany

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred

  • Deadline: 31 Jul 2026
  • Ref No: 5978310
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg

  • Deadline: 10 May 2026
WhatsApp Chat